These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3865972)

  • 1. [Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
    Inoue M; Saitoh J; Abe Y; Inoue Y; Ueda G; Tanizawa O; Gamoh Y; Dan A; Satoh T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2411-4. PubMed ID: 3865972
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum CA 125 levels in preoperative evaluation of pelvic masses.
    Vasilev SA; Schlaerth JB; Campeau J; Morrow CP
    Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
    Iwasaka T; Ohkuma Y; Yoshimura T; Sugimori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum levels of CA-125 in patients with endometriosis: a preliminary report.
    Giudice LC; Jacobs A; Pineda J; Bell CE; Lippmann L
    Fertil Steril; 1986 Jun; 45(6):876-8. PubMed ID: 3458595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
    Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of a new tumor marker for breast carcinoma and ovarian carcinoma].
    Hoffmann L
    Dtsch Med Wochenschr; 1987 May; 112(21):847-9. PubMed ID: 3472869
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
    Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruation.
    Masahashi T; Matsuzawa K; Ohsawa M; Narita O; Asai T; Ishihara M
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):328-31. PubMed ID: 3165507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA-125 and uterine leiomyomas.
    Scarpellini F; Minozzi M; Curto C; Scarpellini L
    Acta Eur Fertil; 1993; 24(2):75-6. PubMed ID: 8171926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
    Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
    O'Connell GJ; Ryan E; Murphy KJ; Prefontaine M
    Obstet Gynecol; 1987 Dec; 70(6):930-2. PubMed ID: 3479735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Katakami Y; Kiyozuka Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2327-35. PubMed ID: 6598184
    [No Abstract]   [Full Text] [Related]  

  • 19. CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
    Canney PA; Wilkinson PM; James RD; Moore M
    Br J Cancer; 1985 Jul; 52(1):131-3. PubMed ID: 2410004
    [No Abstract]   [Full Text] [Related]  

  • 20. [Monoclonal antibodies in the radioimmunological diagnosis of malignant tumors of the gastrointestinal tract and ovaries].
    Tkacheva GA; Blokhina NG; Klimenkov AA; Kozachenko VP
    Vopr Onkol; 1985; 31(5):36-42. PubMed ID: 2409674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.